Remote Blood Pressure Monitoring for Pregnant People With Chronic Hypertension
Tests daily home blood pressure checks and medicine adjustments in pregnant adults with chronic hypertension.
Plain-language title generated from the registry record
Registry title: Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)
Key facts
- Where
- New Brunswick, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
Source: NCT07115199, who can take part
Where in United States
- Rutgers, Robert Wood Johnson Medical SchoolNew Brunswick, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Rutgers, The State University of New Jersey
- Trial code
- NCT07115199
- Record updated
- 8 July 2026
- Original description
We hypothesize that frequent remote monitoring of blood pressure and real-time antihypertensive medication titration will optimize pregnancy outcomes in a clinically meaningful and cost-effective manner compared to the current standard of care. Therefore, this pilot study, as part of the K12 training support, will evaluate the feasibility of a randomized clinical trial to treat mild chronic hypertension with medication therapy to a blood pressure goal of less than 140/90 mmHg based on remote daily patient monitoring compared to in-office blood pressure readings.Read full original descriptionShow less
Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)
We hypothesize that frequent remote monitoring of blood pressure and real-time antihypertensive medication titration will optimize pregnancy outcomes in a clinically meaningful and cost-effective manner compared to the current standard of care. Therefore, this pilot study, as part of the K12 training support, will evaluate the feasibility of a randomized clinical trial to treat mild chronic hypertension with medication therapy to a blood pressure goal of less than 140/90 mmHg based on remote daily patient monitoring compared to in-office blood pressure readings.
Inclusion: Age 18 or older; Patients with a viable pregnancy <23 weeks of gestation; Chronic hypertension is defined as: 1) Currently receiving treatment for hypertensive disorders OR 2) Newly diagnosed or untreated chronic hypertension is defined as systolic blood pressure >=140 mm Hg or diastolic blood pressure >=90 mm Hg prior to 20 weeks of gestation; Viable pregnancy <23 weeks of gestation; Ability to follow directions; Ability to consent; Speak English or Spanish.
Exclusion: Known secondary cause of hypertension; Any medical condition that the providers feel is a contraindication to the REACH algorithm; Known major fetal anomaly; Known fetal demise; Suspected fetal growth restriction; Membrane rupture; Planned termination; Plan to deliver outside of the RWJ Barnabas Health system; Known sensitivity to labetalol or nifedipine; Unlikely to follow up, in the opinion of the study staff; Unwillingness to take blood pressure at home.